Skip to content

FX Effect on Cash at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$48M-173%
Gilead Sciences logo
Gilead SciencesGILD
-$11M-158%
Nuvation Bio logo
Nuvation BioNUVB
-$172K-214%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$122K+1,320%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
-$988K
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$19K-150%

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%
EPS (diluted)-$0.19+47.2%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Market cap$1.9B+32.4%

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s FX effect on cash?
Iovance Biotherapeutics, Inc. (IOVA) reported FX effect on cash of -$213K in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s FX effect on cash changed year-over-year?
Iovance Biotherapeutics, Inc.'s FX effect on cash decreased by 141.9% year-over-year, from $508K to -$213K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.